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Abstract
In a Swedish sample of persons eligible for disability services and aged 55 years or older in 2012, persons (n = 601) with 
autism spectrum disorder diagnoses registered in specialist care were identified. Register data concerning diagnoses of other 
psychiatric disorders, psychiatric care, and psychiatric medication were reviewed. More than 60% had been in contact with 
psychiatric care. The majority had no intellectual disability (ID) diagnosis recorded during the study period. Apart from ID, 
affective disorders, anxiety and psychotic disorders were most commonly registered; alcohol/substance abuse disorders were 
uncommon. Psychotropic drug prescriptions were very common, especially in the ID group. Professionals need awareness 
of this vulnerable group; studies concerning their life circumstances and service requirements should be conducted.
Keywords Older adults · Autism spectrum disorders · Psychiatry
Introduction
Autism spectrum disorders (ASDs) are often presumed to 
be life-long disabilities. There are several follow-up stud-
ies showing that these disorders, which in all cases are 
present at an early age, are relatively stable from childhood 
to adolescence (Nordin and Gillberg 1998; Szatmari et al. 
2009), and, especially if accompanied by intellectual dis-
ability (ID), into adulthood (Billstedt 2007). In a review of 
23 follow-up studies, Howlin and Moss (Howlin and Moss 
2012) found that as adults, many individuals with ASD were 
significantly disadvantaged in several ways, including physi-
cal and mental health. Although two studies of the same 
Swedish cohort with normal IQ ASD (n = 47) showed that 
the number who met diagnostic criteria for any ASD slowly 
diminished (Cederlund et al. 2008; Helles et al. 2015), 76% 
still had the number of symptoms required for an ASD diag-
nosis even in the follow-up study at mean age 30 years.
Only two of the 23 studies in the Howlin and Moss review 
included any individuals older than 50 years, and most ASD 
research today is still on children (Howlin 2008; Howlin 
and Moss 2012; Mukaetova-Ladinska et al. 2012). Thus, 
very little is known about ASD in people older than around 
50 years (Happé and Charlton 2011; Perkins and Berkman 
2012; Barber 2015; Lai and Baron-Cohen 2015; Bennett 
2016) and only recently has work been commenced in this 
area. Among other things, it is not known how many older 
individuals have diagnosed ASDs, how ASD is expressed in 
older people, or if coexisting physical and mental disorders 
are common. In recent years, there have been some studies 
on this subject, primarily in the UK (James et al. 2006), the 
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US (Kats et al. 2013), and the Netherlands (van Niekerk 
et al. 2010; Geurts and Vissers 2011; van Heijst and Geurts 
2014; Geurts et al. 2016; Lever and Geurts 2016). However, 
the knowledge concerning this group is still very limited, 
both in Sweden and in most other countries.
A previous study by the research team (Axmon et al. 
2016) examined use of psychiatric services in a sample of 
older adults (n = 7936, mean age 53, age range 44–85) from 
the general population, and found that only 6.4% had any 
registered visit to psychiatric care (inpatient or outpatient) 
during the 11-year period that the study comprised. Older 
people with ID had higher inpatient and outpatient care uti-
lisation (OR 3.59).
In this study we focused on ASD, more specifically in 
the older adult Swedish population eligible for municipal 
services. The aim was to investigate the prevalence of indi-
viduals with ASD diagnoses from specialist care, with and 
without concurrent diagnoses of ID of varying severity. The 
term “specialist care” refers to all medical clinics that are 
not considered primary care, or general practice. The aims 
included investigation of the pattern of coexistent psychi-
atric diagnoses and the utilisation of psychiatric care and 
psychotropic medication among any individuals found to 
have ASD diagnoses.
Materials and Methods
The present study is a nation-wide register study conducted 
in Sweden and comprising the years 2002–2012, with the 
exception of data on prescribed drugs which have been 
obtained from 2006 only.
National Registers Used in the Study
In Sweden, individuals with permanent and considerable 
functional impairment can apply for municipal services 
according to the Act Concerning Support and Service for 
Persons with Certain Functional Impairments (Swedish 
abbreviation: LSS; 1993:387). The Act covers individuals 
who can be categorised as belonging to one of three specific 
groups. Group 1 consists of people who have been diagnosed 
with ID and/or ASD, and are thus in need of services. Group 
2 consists of people with cognitive disability after sustaining 
brain injury/damage in adulthood, while Group 3 consists 
of people in need of support due to other permanent and 
considerable disabilities that hinder their ability to function 
in daily life. Group 1 is thus the only group that is defined 
mainly by diagnosis.
Individuals provided with support from the municipality 
under the umbrella of this act are included in the LSS-reg-
ister as well as data on which type of support they received. 
This register is maintained by the Swedish National Board 
of Health and Welfare and does not contain information on 
individuals’ diagnoses, only on their LSS-group classifica-
tion. The register contains only those who, after their own 
application, have been found to meet criteria to be given 
support. Thus, not everyone diagnosed with ASD or even ID 
can be expected to be registered, which means that a number 
of people with ASD, especially people with normal IQ, may 
not be included in the study group.
The Swedish National Board of Health and Welfare also 
maintains The Swedish National Patient Register (NPR). 
The NPR contains information on all individuals using in- 
and outpatient specialist medical care in Sweden. It contains 
no information about visits to primary health care. Specialist 
psychiatric care includes all psychiatric inpatient care, as 
well as any outpatient care considered to require resources 
above the primary care level. Registration in the NPR is 
made at the date of discharge for inpatient care, and at the 
date of the visit for outpatient care. Every time a patient is 
registered in this way, one primary and up to 21 secondary 
diagnoses are listed. Diagnoses are coded according to the 
10th revision of the International Classification of Disease 
(ICD-10) (WHO 1993). Diseases and/or conditions that are 
not the focus of the care episode may or may not be regis-
tered as secondary diagnoses, depending on their relevance 
to the circumstances, local procedures, or the physician’s 
own preferences. It is not possible to find information in 
the NPR on where or when any diagnosis was first made. 
In the ICD-10, the term “mental retardation” is used rather 
than “intellectual disability”. However, as “intellectual dis-
ability”/ID is the currently preferred term (Schalock et al. 
2007), we will use this henceforth.
Also the Swedish Prescribed Drug Register (PDR) is kept 
at the Swedish National Board of Health and Welfare, and 
contains information from July 2005 onwards on dispensed 
prescribed drugs (Wettermark et al. 2007).
Study Population
Through the LSS register, we identified 7936 persons (3609 
women and 4327 men) in Sweden who met the following 
criteria: (1) they were 55 years or older on December 31st, 
2012, (2) they belonged to LSS-group 1 (i.e. had been diag-
nosed with ID and/or ASD), (3) they had received at least 
one service according to LSS during 2012, and (4) they were 
alive at the end of 2012. As outcome data was obtained for 
the time period 2002–2012, information was collected for 
persons aged 44 years and above. The mean age on Decem-
ber 31, 2012, was 64 years (range 55–96 years).
All individuals who, during the period examined 
(2002–2012), had a registered diagnosis of any ASD—
defined as an ICD-10 code for pervasive developmental dis-
order (PDD), F84.0-84.9 (n = 606, 7.63%)—were extracted 
using the diagnoses registered in the NPR. Five of these 606 
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were excluded: four women with Rett’s syndrome, F84.2, 
as single diagnosis and one man with other childhood dis-
integrative disorder (F84.3), leaving 601 persons (385/64% 
males and 216/36% females) in the study group. However, 
several individuals (103; 17%) had more than one F84 diag-
nosis, two of which had as many as four different diagno-
ses. Therefore, diagnoses were ranked in order to classify 
each person with only one F84 diagnosis. The chosen rank 
order was childhood autism (F84.0), Asperger’s syndrome 
(F84.5), atypical autism (F84.1), other PDD (F84.8) and 
PDD, unspecified (F84.9), based on the assumption that 
childhood autism and Asperger’s syndrome, respectively, 
refer to more “typical” variants of ASD than the follow-
ing terms. Only three individuals in the sample had been 
registered with both childhood autism (F84.0) and Asper-
ger’s syndrome (F84.5) diagnoses. Since 1419 persons in 
the LSS group were not registered in the NPR, i. e. did not 
visit inpatient or outpatient specialist care during the period 
examined, we have no information regarding their possible 
ASD diagnoses. The 601 remaining individuals with regis-
tered ASD diagnoses will be referred to below as the ASD 
group. All persons in the ASD group had at least one point 
of registration in the NPR during 2002–2012, meaning that 
they had been in contact with specialist medical care and 
that ASD had been observed by the physician.
Data concerning gender, other psychiatric diagnoses, psy-
chiatric care utilisation and psychotropic medication were 
reviewed, using data from the NPR (2002–2012) and PDR 
(2006–2012).
In the NPR, the type of clinic where each visit is made 
is registered based on codes determined by the Swedish 
National Board of Health and Welfare. For this study, the 
nine different types of adult psychiatric services were 
collapsed into three groups, namely “general adult psy-
chiatric service” (also encompassing “psychiatric nursing 
home”, “geropsychiatric service”, “specialised psychiatric 
care” and “psychiatric rehabilitation”), “forensic psychi-
atric care on regional level” and “substance dependency 
treatment” (also including “alcohol dependency care” and 
“toxicomania care”). Registrations in any type of psychi-
atric clinic were considered in total (any registration), as 
well as inpatient and outpatient registrations separately. 
We also calculated the mean and median number of days 
in inpatient care for each of the ASD groups.
Three patient records were registered as “psychiatric 
care for children and adolescents” and four records were 
missing information on type of clinic and were therefore 
excluded in this study, as were 73 records which were 
duplicates with respect to person, clinic and date.
A number of individuals with ASD diagnoses also had 
registered ID (ICD-10 code F70-79) diagnoses during the 
period examined. In some cases a person had been diag-
nosed with ID of different severities on different visits. 
We have chosen a rank order where a specified ID takes 
precedence over an unspecified ID, and the most severe 
ID diagnosis takes precedence over the milder variants. 
Concomitant psychiatric diagnoses other than ID were cat-
egorised in nine groups: ADHD (F90), psychotic disorders 
(F2), affective disorders (including bipolar) (F3), anxiety 
disorders (F40-42), personality disorders (F60-61), alco-
hol/substance use related disorders (F1 except F10.7A), 
dementia (F00-03, F10.7A, F05.1) and other psychiatric 
disorders (all other registered F diagnoses not belonging 
to any of the above-mentioned groups).
From the PDR, information was collected concerning 
certain psychotropic drugs, grouped according to the Ana-
tomical Therapeutic Chemical Classification (ATC-code). 
The drug categories chosen were antipsychotics (ATC-
code N05A), anxiolytics (N05B), hypnotics and sedatives 
(N05C) and antidepressants (N06A).
Figure 1 shows the procedure of data inclusion.
Fig. 1  Data catchment proce-
dure
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Ethics Approval and Consent to Participate
The study was approved by the Regional Ethical Review 
Board. This study is part of a larger project, which used 
anonymised datasets drawn from four—in the present 
study three—official national registries maintained by 
the National Board of Health and Welfare and Statistics 
Sweden. The National Board of Health and Welfare and 
Statistics Sweden provided separate secrecy reviews in 
2014 before access to the data. Due to the requirement 
for anonymised data, individuals could not be asked for 
consent to participate; instead the reverse principle was 
applied, with active refusal of participation required 
to avoid inclusion in the study. Information about the 
planned study was published in the national newspaper 
‘Dagens Nyheter’ and one version was easy-to-read text 
for the UNIK, the magazine of the Swedish National 
Association for Persons with Intellectual Disability 
(print run of 22,000 copies). The target audience for the 
UNIK magazine are mainly members (people with ID) 
and their families. The advertisement presented the study 
and contained information on how to contact the research 
manager by phone, email or mail to opt out of the study. 
The research manager was responsible for contacting the 
national registries to ensure that those not wanting to par-
ticipate were excluded before the registries provided any 
data to the research manager. There were no refusals to 
participate.
Funding
This work was funded by the Swedish Research Council 
for Health, Working Life and Welfare. The funding agency 
had no role in the design, analysis, and interpretation of this 
study. The requirement from the national fund is only Open 
Access publishing.
Results
Figure 2 shows gender and birth year distribution for the 
five categories of ASD in the study group (n = 601). The 
age range in 2012 was 55 to 96 years. Childhood autism 
(F84.0) is the most common diagnosis irrespective of gen-
der or age. Asperger’s syndrome (F84.5) is more common 
in persons born 1950 or later than in older persons. Slightly 
more women than men had atypical/unspecified ASD diag-
noses, which was also seen in the patients born before rather 
than after 1950.
Table 1 shows ASD categories in relation to concomi-
tant ID (F7) diagnoses. There were no ID diagnoses regis-
tered for 345 persons (57%). Mild ID (6%) was less com-
mon than severe/profound (11%), and most common was 
other/unspecified ID (19%). Thirteen individuals (9%) of 
the Asperger’s syndrome group—commonly defined as 
ASD in the presence of a normal or high intellectual level 
and useful language—were assigned ID diagnoses of dif-
ferent severities, one of them even classified as severe/
Fig. 2  Percentage of different ASD-diagnoses within each ID category (y-axis), with each bar marked with the actual number of people
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profound. Forty-eight individuals (42%) in the group with 
other/unspecified ID had atypical/other/unspecified ASD 
diagnoses, and 19% of the ASD group had been assigned 
other/unspecified ID diagnoses.
Of the 601 persons with ASD, 86 had two different 
ASD diagnoses, 15 had three different diagnoses and two 
had four different diagnoses.
Figure  3 shows that, apart from the heterogeneous 
group “other psychiatric disorders”, affective disorders 
were the most commonly registered conditions, followed 
by anxiety and psychotic disorders. This pattern is fairly 
consistent across the ASD categories. The group with no 
ID dominates among those with registered psychiatric 
diagnoses. Most common in this group were affective and 
anxiety disorders. People with ASD and ID have also often 
been diagnosed with psychiatric disorders, especially dis-
orders in the “other” group.
A small number of patients had been diagnosed with 
ADHD. Similar to alcohol and/or substance use-related 
disorders, ADHD was diagnosed mainly in the group with-
out ID.
Table 2 shows the number of persons with psychiatric 
care utilisation as well as the number of psychiatric care 
visits. Number of visits (out-patient as well as in-patient) 
to different categories of adult psychiatric care is shown, as 
well as number of days as psychiatric inpatient for the five 
ASD categories. Almost all visits are made in clinics belong-
ing to the category “general adult psychiatric care”. Visits 
to clinics giving forensic psychiatric care had been made 
by people diagnosed with Asperger’s syndrome (F84.5) and 
PDD, unspecified (F84.9). Only individuals with an Asper-
ger’s syndrome diagnosis, had made visits to substance 
dependency treatment clinics. The group with Asperger’s 
syndrome had the highest number of people who had spent 
time as psychiatric inpatients. 220 (37%) of the 601 persons 
had not been in psychiatric care during the period examined. 
Their ASD diagnoses have thus been registered in somatic 
specialist care.
Table 3 shows number, percentages and the OR for using 
any specialist psychiatric care for the ASD subgroups, ID 
versus no ID, gender and age group, respectively. The OR 
for people with Asperger’s syndrome to have contact with 
specialist psychiatry was almost seven compared to people 
Table 1  Number and percentage of individuals with ASD diagnoses within each ID category
Mild ID Moderate ID Severe/profound ID Other/unspecified ID No ID diagnosis
n (%) n (%) n (%) n (%) n (%)
F84.0 childhood autism n = 240 16 (6.7) 19 (7.9) 35 (14.6) 65 (27.1) 105 (43.8)
F84.5 Asperger syndrome n = 141 7 (5.0) 2 (1.4) 1 (0.7%) 3 (2.1) 128 (90.8)
F84.1 atypical autism n = 86 4 (4.7) 4 (4.7) 13 (15.1) 22 (25.6) 43 (50.0)
F84.8 other pervasive developmental 
disorders n = 14
1 (7.1) 0 (0.0) 3 (21.4) 2 (14.3) 8 (57.1)
F84.9 pervasive developmental disor-
der, unspecified n = 120
10 (8.3) 10 (8.3) 15 (12.5) 24 (20.0) 61 (50.8)
Total n = 601 38 (6.3) 35 (5.8) 67 (11.0) 116 (19.3) 345 (57.4)
Fig. 3  Psychiatric diagnoses in 
people with/without ID and in 
the whole
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Table 2  Psychiatric health care utilization
a One person may contribute with more than one visit
Number of visits to different categories of psychiatric 
 clinicsa
Number of people with different psychiatric health 
care utilization
Total number 
of days in 
psychiatric 
inpatient careGeneral adult 
psychiatric 
service
Forensic psy-
chiatric care on 
regional level
Substance 
depen-dency 
treatment
No psychiatric 
care
Psychiatric out- 
but not inpatient 
care
Psychiatric 
inpatient 
care
n (%) n (%) n (%) n (%) n (%) n (%) Mean Median
F84.0 child-
hood autism 
(n = 240)
823 (100) 0 (0) 0 (0) 108 (45) 84 (35) 48 (20) 43 15
F84.5 Asperger 
syndrome 
(n = 141)
1362 (90) 27 (2) 117 (8) 15 (11) 66 (47) 60 (43) 197 65
F84.1 atypical 
autism (n = 86)
280 (100) 0 (0) 0 (0) 37 (43) 37 (43) 12 (14) 33 18
F84.8 other 
pervasive 
developmen-
tal disorders 
(n = 14)
24 (100) 0 (0) 0 (0) 7 (50) 4 (29) 3 (21) 2 2
F84.9 pervasive 
developmen-
tal disorder, 
unspec 
(n = 120)
368 (97) 13 (3) 0 (0) 53 (44) 39 (33) 28 (23) 105 25
Table 3  Any psychiatric care 
versus no psychiatric care Any psychiatric 
care
n (%)
No psychiatric care
n (%)
OR for any psychiatric care 
versus no psychiatric care
95% CI
ASD subgroup
 F84.0 childhood autism 132 (55) 108 (45) Ref
 F84.5 Asperger syndrome 126 (89) 15 (11) 6.87 3.80–12.43
 F84.1 atypical autism 49 (57) 37 (43) 1.08 0.66–1.78
 F84.8 other pervasive 
developmental disorder
7 (50) 7 (50) 0.82 0.28–2.41
 F84.9 pervasive devel-
opmental disorder, 
unspecified
67 (56) 53 (44) 1.03 0.67–1.61
ID/no ID
 No ID 193 (56) 152 (44) Ref
 ID 188 (73) 68 (27) 2.18 1.54–3.09
Gender
 Women 128 (59) 88 (41) Ref
 Men 253 (66) 132 (34) 1.32 0.94–1.86
Age group
 –1944 54 (50) 53 (50) Ref
 1945–1949 93 (61) 60 (39) 1.52 0.92–2.51
 1950–1954 128 (65) 68 (35) 1.85 1.14–2.99
 1955– 106 (73) 39 (27) 2.67 1.57–4.52
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with childhood autism. The OR was also elevated for people 
with ID compared to no ID, for males and for younger versus 
older people.
Table 4 shows the number and percentage of people, cat-
egorised as those with and without a registered ID diagnosis, 
with at least one prescription of psychotropic drugs. The 
drugs investigated were categorised as neuroleptics (N05A), 
anxiolytics (N05B), hypnotics and sedatives (N05C) and 
antidepressants (N06A). The table also shows the number 
and percentage of people prescribed with more than one 
category of the above mentioned drugs.
Discussion
To our knowledge, this register study describes the largest 
group of older adults with ASD diagnoses that has ever been 
studied. Several authors (e. g. Happé and Charlton 2011; 
Perkins and Berkman 2012; Bennett 2016) have described 
the need for research and data on older people with ASD, 
and our study provides knowledge concerning psychiatric 
diagnoses, psychiatric care and psychotropic medication.
The most common ASD diagnosis in the group was child-
hood autism (F84.0), often regarded as the most severe form 
of ASD. This may be due to diagnostic traditions—with only 
one available autism diagnosis instead of a spectrum—when 
the persons were young and the autism diagnosis was first 
made, and/or the selection of the group being based on their 
need for extensive help. In the younger subgroup (born after 
1950), Asperger’s syndrome (F84.5) was a more common 
diagnosis than in the older part of the group. Since we have 
no way of knowing when any diagnosis in the group was 
first made, we have no explanation for this, other than that 
the Asperger’s syndrome diagnosis was first listed in ICD-10 
(WHO 1993) and that it has slowly become more well-
known and used in the past 10–15 years. However, since the 
more recent diagnostic manual DSM-5 (American Psychiat-
ric Association 2013) lists only one label, autism spectrum 
disorder (ASD), it is to be expected that other diagnoses, 
e.g. childhood autism or Asperger’s syndrome, will be less 
used in the future.
Studies from recent years have shown that ASD may be 
more difficult to diagnose in females than in males (Mandy 
et al. 2012; Frazier et al. 2014) and this is indicated by our 
study as well, where there was a tendency towards other or 
unspecified ASD being more common among women than 
in men. The same tendency was seen in the older ASD group 
as compared with the younger one. However, tendencies in 
this study must be regarded with caution, since no measures 
of statistical significance are included.
The majority of the group had no registered ID diagnosis. 
This could be due either to under registration of ID, or to 
ASD being diagnosed in increasing numbers in individuals 
with intellectual functioning in the normal range, includ-
ing in older adults. Surprisingly, mild ID was less common 
than severe ID in the ASD group, and most common was 
other/unspecified ID. This is probably an effect of the ID 
diagnoses being registered in connection with visits in the 
care system on account of symptoms of illness rather than 
after a cognitive assessment; moreover, the physicians in 
question may have had registered information provided to 
them by care staff from social services in the event that he/
she did not have access to earlier evaluations. If care staff 
found information about ASD more pertinent, mild ID may 
have stayed unregistered. Furthermore, severe/profound ID 
may be more conspicuous during a medical examination. 
Also, it is more likely that individuals with more severe 
impairments and pervasive needs are registered in the LSS 
register. This register, as mentioned above, can thus not be 
expected to include all people with ASD, which is a limita-
tion to this study.
As in general adult psychiatry, apart from the heterogene-
ous group “other psychiatric disorders”, affective disorders 
were the most commonly diagnosed concomitant psychiat-
ric disorders, followed by anxiety and psychotic disorders, 
in the total ASD sample. Patients with childhood autism 
(F84.0) and ID had more “other” psychiatric disorders than 
the other groups, which may reflect diagnostic difficul-
ties with patients who often have very low communicative 
skills. Affective and anxiety disorders were often diag-
nosed in patients with Asperger’s syndrome (F84.5) with-
out ID, which is in concordance with other studies (Lever 
and Geurts 2016). Alcohol and/or substance use-related 
disorders were diagnosed mainly in the group without ID, 
probably reflecting the fact that the more disabled persons 
had very limited access to the pathogens in question. Only 
patients with Asperger’s syndrome diagnoses had been 
Table 4  Individuals with ASD diagnoses and at least one prescrip-
tion of psychotropic drugs (antipsychotics, anxiolytics, hypnotics and 
sedatives, antidepressants)
No ID diagnosis 
(n = 345)
ID diagno-
sis (n = 256)
n (%) n (%)
At least one prescription of
 Antipsychotics  217 (63) 214 (84)
 Anxiolytics  204 (59) 198 (77)
 Hypnotics and sedatives  172 (50) 145 (57)
 Antidepressants 171 (50) 152 (59)
No of psychotropic drugs
 0 46 (13) 12 (5)
 1 65 (19) 26 (10)
 2 69 (20) 49 (19)
 3 99 (29) 91 (36)
 4 66 (19) 78 (30)
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visiting specialist clinics for these disorders, which, accord-
ing to clinical experience, may also be underdiagnosed and 
thus undertreated in persons with ID.
Our results are, to a great extent, in line with the earlier 
studies on adults with ASD, which have shown that con-
comitant psychiatric symptoms and diagnoses are common 
(Hutton et al. 2008; Hofvander et al. 2009; Buck et al. 2014; 
Hirvikoski et al. 2016; Helles et al. 2015), also when com-
pared to other psychiatrically referred adults (Joshi et al. 
2013). Patients with Asperger’s syndrome diagnoses, F84.5 
and no ID make up the majority among those with regis-
tered psychiatric diagnoses. Affective and anxiety disorders 
were the most common concurrent disorders, as was the case 
in for example the younger normal IQ sample studied by 
Hofvander et al. (2009). Similarly, Hutton et al. (2008) also 
reported that mood disorders were the most frequent new-
onset psychiatric disorders in their study group. In contrast 
to the latter study, where 43% of 122 persons with ASD also 
had ADHD, we found only 4% with a registered diagnosis 
of ADHD. This may indicate that awareness of the possible 
existence of ADHD not only in children and young adults 
but also in older adults is a recent phenomenon (Michielsen 
et al. 2012; Guldberg-Kjär et al. 2013). The former belief, as 
expressed in the DSM-IV (American Psychiatric Associa-
tion 1994), that ADHD should not be diagnosed in individu-
als with ASD, may also provide an explanation for these low 
numbers of ADHD diagnoses.
In our study, the total number of individuals diagnosed 
with any psychotic disorder was 71, or almost 12%; this 
figure roughly matches the findings of Hofvander et al. 
(2009), while Lever and Geurts (2016) had schizophrenia 
as an exclusion criterion. In another sample from an adult 
psychiatric clinic (n = 270), 21% had been diagnosed with 
a psychotic disorder (Nylander et al. 2012); and in a recent 
population-based study, Supekar et al. (2016) found a preva-
lence of 18% for schizophrenia in adults 35 years or older 
with ASD. Thus, our results do not differ from other find-
ings, and point toward a high prevalence of psychotic disor-
ders in middle-aged or older individuals with ASD.
In a recent study by Lever andGeurts (2016), examining 
48 individuals with ASD, 55–79 years old and with IQ > 80, 
66.9% were found to have some kind of lifetime psychiat-
ric disorder, and 44% reported symptoms consistent with a 
mood disorder diagnosis. Lever and Geurts also found that 
self-reported psychiatric symptoms were more common in 
this ASD group of older people than in an age-matched con-
trol group, but less common than in two comparison groups 
of younger people with ASD. In our sample, which is not 
based on self-reported lifetime symptoms but on registered 
diagnoses, 49.6% of the whole ASD group had some kind of 
psychiatric diagnosis during the period examined, and 19.6% 
had had a mood disorder diagnosis. Of the group (n = 345) 
who had no ID diagnosis registered, 69.2% had some kind of 
psychiatric diagnosis but only 10.8% had affective disorder 
diagnoses. Twelve percent had some kind of psychotic dis-
order diagnosis, which is the same prevalence as was found 
by Hofvander et al. (2009).
Of our ASD group, 381 patients (63.4%) had been in con-
tact with specialised psychiatric care and 151 (25%) had 
been in-patients during the period examined. This exceeds 
the numbers (20% in contact with psychiatric care) reported 
by Axmon et al. (2016) for the larger group of older people 
eligible for LSS services, which in turn exceeded the 6% in 
the matched group from the general population. Only 15 
individuals, or 11%, of the group with Asperger’s syndrome 
had not been in contact with psychiatric care, and 43% had 
been psychiatric in-patients, which may be interpreted as a 
sign of vulnerability in these individuals. The OR for being 
in contact with specialist psychiatry was almost seven times 
higher for people with Asperger’s syndrome compared to 
people with childhood autism. Also, people with Asperger’s 
syndrome exclusively had been in contact with substance 
dependency treatment clinics or forensic psychiatry, which 
may point to a greater risk for substance dependency and/
or criminal behaviour in this intellectually more able group. 
Other factors raising the OR for psychiatric contact were the 
presence of ID, male gender and belonging to the younger 
rather than older group.
Other authors have found that psychotropic medication, 
including polypharmacy, is frequently prescribed to adults 
with ASD (Esbensen et al. 2009; Åkerström 2001; Buck 
et al. 2014; Jobski et al. 2017). In the group that we studied, 
63% of patients without registered ID diagnosis and as many 
as 84% of those with ID in combination with ASD had been 
prescribed antipsychotic medication. This is in contrast to 
the number (12%) of individuals with diagnosed concomi-
tant psychotic disorders but may be seen as an indication 
that it is common practice to treat people with ASD, espe-
cially if they also have ID, with antipsychotics as a way of 
managing behaviours. The effects and side effects of these 
treatments in adults and older adults require investigation 
(Näslund 2007). Also the other categories of psychotropic 
drugs investigated were more frequently prescribed to 
individuals with double diagnoses. Three or four different 
psychotropic drugs were prescribed to 32 and 24% of all 
individuals examined, respectively. Only 58 (9.6%) of all 
indiviuals in the study had not been prescribed any of the 
studied psychotropic drugs during the study period, although 
50% had no psychiatric diagnosis other than ASD, with or 
without ID registered. Compared to other findings, e.g. those 
of Jobski et al. (2017), this group of older adults with ASD 
were very often prescribed psychotropic drugs.
We have no way of knowing to what extent the group in 
our study is representative for all older adults in Sweden 
with ASD. The group was selected according to three crite-
ria: (1) having received LSS service in 2012, (2) having been 
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in contact with secondary health care and (3) having been 
assigned an ASD diagnosis during 2002–2012. It is likely 
that several individuals in the studied age group had not 
been given any LSS service, and/or not been in contact with 
health care, and/or not assigned an ASD diagnosis when 
seeking medical care. It is also probable that some individu-
als with ASD have not been classified in LSS group 1, but 
have received services resulting from classification in one of 
the other two groups. However, since 87% of all LSS service 
users have been classified in LSS group 1 (Socialstyrelsen 
2017), the number of older people with ASD in LSS groups 
2 or 3 is probably very small. Our results should thus be 
seen as minimum numbers, and to our knowledge it is the 
largest group of older adults with ASD hitherto described 
in the world. The selection of cases on the basis of the LSS-
register does “guarantee” that the individuals included had 
significant functional impairments, and therefore meet the 
basic requirements for an ASD diagnosis.
The results showed that there are older people in Sweden 
with ASD diagnoses who have significant needs for ser-
vices, and who require psychiatric specialist services due to 
concomitant psychiatric disorders. It seems that the group 
with Asperger’s syndrome, or ASD without ID, is especially 
vulnerable to psychiatric disorders. There is, as a number of 
authors have pointed out, a lack of research concerning ASD 
in this age group, and it is likely that ASD is underdiagnosed 
and that older individuals with ASD are provided with inad-
equate support due to this lack of knowledge. Still, not much 
is known concerning which socio-economic conditions older 
individuals with ASD live under, which services they need 
or which services they actually are offered.
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